Charlotte Wagner

16PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyMolecular medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 21, 2026
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.

Cindy Varga, Myra Robinson, James A Davis

|Dec 17, 2025
Cost-effectiveness of chimeric antigen receptor T-cell therapy for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis.

Taylor J Loftus, Jeong-Yeon Cho, Manuel Meraz

|Aug 01, 2025
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.

Binod Dhakal, Othman S Akhtar, David Fandrei

|Jul 16, 2025
Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis.

Kritika Yadav, Meera Mohan, Charlotte Wagner

|Mar 15, 2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.

Rahul Banerjee, Alicia Richards, Shonali Midha

|Mar 04, 2025
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.

James A Davis, Jordan Snyder, Mikhaila Rice

Pageof 3

Frequent Collaborators

9 joint publications

Surbhi Sidana

8 joint publications

Douglas W Sborov

8 joint publications

Krina Patel

7 joint publications

Jack Khouri